MiR-540 as a novel adipogenic inhibitor impairs adipogenesis via suppression of PPARγ

Lin Chen1, Yuanwei Chen, Sheng Zhang

  • 1State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, P. R. China; Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital, Central South University, Changsha, 410011, P. R. China.

Insights

MicroRNAs regulate fat cell differentiation. This study identifies miR-540 as a key inhibitor of adipogenesis in adipose tissue-derived stromal cells by targeting PPARγ, offering insights into metabolic diseases.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cell Biology

Background:

  • Adipogenesis, the process of fat cell formation, is crucial for understanding adipose tissue-related diseases.
  • MicroRNAs (miRNAs) are emerging as significant epigenetic regulators in stem cell differentiation.
  • Identifying novel regulators of adipogenesis is key to developing therapeutic strategies for metabolic disorders.

Purpose of the Study:

  • To investigate the role of miR-540 in the regulation of adipogenic differentiation.
  • To elucidate the molecular mechanisms by which miR-540 influences adipogenesis.
  • To determine if miR-540 can be targeted as an adipogenic inhibitor.

Main Methods:

  • Overexpression and inhibition of miR-540 using lentiviral vectors in adipose tissue-derived stromal cells (ADSCs).
  • Analysis of key adipogenic transcription factors, including C/EBP-α and PPARγ.
  • Assessment of lipid accumulation via biochemical assays.
  • Target gene validation using 3'-untranslated region (3'UTR) reporter assays.

Main Results:

  • Overexpression of miR-540 blocked adipogenesis, reducing C/EBP-α and PPARγ expression and lipid accumulation in ADSCs.
  • Inhibition of miR-540 promoted adipogenic differentiation.
  • miR-540 was confirmed to directly target the 3'UTR of PPARγ, leading to decreased PPARγ protein levels.

Conclusions:

  • miR-540 acts as a critical negative regulator of adipogenesis in ADSCs.
  • The mechanism involves direct targeting of PPARγ, a master regulator of adipogenesis.
  • miR-540 represents a potential therapeutic target for modulating adipose tissue function and related diseases.